Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...
Get the best of the Pacific in your inbox!
After a sloppy start, Houston outscores New Orleans 33-15 in third quarter and then hangs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback